Ren Yuan, Zha Xiao, Zhang Guo-nan
Department of Molecular Pharmacology, Sichuan Tumor Hospital, Chengdu 610041, China.
Zhonghua Yi Xue Za Zhi. 2007 May 8;87(17):1204-6.
To study the inhibitory effect of tirapazamine (TPZ) combined with LY294002, an inhibitor of phosphatidylinositol 3-kinase (PI3K), on the growth of human ovarian carcinoma cells.
Human ovarian carcinoma cells of the line HO8910PM were cultured and treated with tirapazamine alone and treated with TPZ of different concentrations combined with LY294002 of the concentration of 50 micromol/L respectively under aerobic and hypoxic conditions. And human ovarian carcinoma cells of the line OVCAR-3 were cultured and treated with YPZ alone and treated with TPZ of different concentrations combined with LY294002 of the concentration of 25 micromol/L respectively under aerobic and hypoxic conditions. MTT method was used to detect the surviving fractions of these carcinoma cells.
The IC(50) values of TPZ on the HO8910PM cells under hypoxic condition was 40.6 micromol/L, significantly lower than that under aerobic condition (53.0 micromol/L, P < 0.01). The IC(50) values of TPZ on the OVCAR-3 cells under hypoxic condition was 65.9 micromol/L, significantly lower than that under aerobic condition (97.4 micromol/L, P < 0.01). The IC(50) value of TPZ combined with LY294002 on the HP8910PM cells under hypoxic condition was 22.7 micromol/L, significantly lower than that under aerobic condition (31.5 micromol/L, P < 0.01). The IC(50) value of TPZ combined with LY294002 on the OVCAR-3 cells under hypoxic condition was 49.1 micromol/L, not significantly different from that under aerobic condition (51.0 micromol/L, P > 0.05).
TPZ inhibits the growth of human ovarian carcinoma cells. The inhibitory effects of TPZ on the growth of human ovarian carcinoma cell of the lines HO8910PM and OVCAR-3 under hypoxic conditions are significantly higher than those under aerobic condition1. LY294002 increases the inhibitory effect of TPZ on the ovarian cancer cells, compared with TPZ treatment alone, TPZ combined with LY294002 decreases the IC(50) of HO8910PM and OVCAR-3 cells significantly.
研究替拉扎明(TPZ)联合磷脂酰肌醇3激酶(PI3K)抑制剂LY294002对人卵巢癌细胞生长的抑制作用。
培养人卵巢癌细胞系HO8910PM,分别在有氧和缺氧条件下单独用替拉扎明处理,以及用不同浓度的TPZ与浓度为50微摩尔/升的LY294002联合处理。培养人卵巢癌细胞系OVCAR-3,分别在有氧和缺氧条件下单独用YPZ处理,以及用不同浓度的TPZ与浓度为25微摩尔/升的LY294002联合处理。采用MTT法检测这些癌细胞的存活分数。
缺氧条件下TPZ对HO8910PM细胞的IC50值为40.6微摩尔/升,显著低于有氧条件下的(53.0微摩尔/升,P<0.01)。缺氧条件下TPZ对OVCAR-3细胞的IC50值为65.9微摩尔/升,显著低于有氧条件下的(97.4微摩尔/升,P<0.01)。缺氧条件下TPZ联合LY294002对HP8910PM细胞的IC50值为22.7微摩尔/升,显著低于有氧条件下的(31.5微摩尔/升,P<0.01)。缺氧条件下TPZ联合LY294002对OVCAR-3细胞的IC50值为49.1微摩尔/升,与有氧条件下的(51.0微摩尔/升,P>0.05)无显著差异。
TPZ抑制人卵巢癌细胞生长。缺氧条件下TPZ对HO8910PM和OVCAR-3人卵巢癌细胞生长的抑制作用显著高于有氧条件下。LY294002增强了TPZ对卵巢癌细胞的抑制作用,与单独TPZ处理相比,TPZ联合LY